Lunai Bioworks Inc. Accounts Payable
Lunai Bioworks Inc. (LNAI) had Accounts Payable of $167.26 thousand as of 2025-09-05, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-15
- 2025-09-05: Accounts Payable, Current $167.26K.
- 2025-07-25: Accounts Payable, Current $17.05K.
- 2017-03-31: Accounts Payable, Current $844.89K.
- 2016-12-31: Accounts Payable, Current $936.75K.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-05 | $167.26K 10-Q · filed 2026-05-15 |
| 2025-07-25 | $17.05K 10-Q · filed 2026-05-15 |
| 2017-03-31 | $844.89K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $936.75K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $979.03K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.09M 10-Q · filed 2017-05-15 |
| 2016-03-31 | $763.76K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $526.35K 10-Q · filed 2016-02-12 |
| 2015-09-30 | $517.54K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $512.78K 10-Q · filed 2016-05-13 |
| 2015-03-31 | $622.19K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $711.45K 10-KT · filed 2015-09-28 |
| 2014-09-30 | $624.04K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $668.87K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $568.17K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $548.50K 10-KT · filed 2015-09-28 |
| 2012-12-31 | $551.17K 10-Q · filed 2014-08-14 |
| 2011-12-31 | $376.00 10-Q · filed 2012-02-21 |
| 2011-09-30 | $75.00 10-Q · filed 2011-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |